Reduced levels of a protein – called apolipoprotein E – are responsible for the lifelong cognitive and neurological symptoms in fetal alcohol spectrum disorders (FASD), according to a new study published in the journal Molecular Psychiatry. For the first time, researchers at Children’s National Hospital are testing whether controlling the level of this protein could serve as an effective treatment for the poor neurobehavioral outcomes tied to FASD, which is believed to affect roughly 5% of school-aged children.
https://innovationdistrict.childrensnational.org/adjusting-key-protein-could-improve-brain-function-in-children-with-fetal-alcohol-syndrome/
No hay comentarios:
Publicar un comentario